"Do we treat a telehealth abortion as happening within the state of the provider or within the state of the patient?" ...

UroGen Pharma shares surged after the company received Food and Drug Administration approval for bladder cancer drug Zusduri, previously known as UGN-102. The stock was recently up 36% to $9.96. Prior ...

The FDA has granted approval to UGN-102 for use in patients with low-grade intermediate-risk non-muscle-invasive bladder ...

A Bergen County spa owner and massage therapist has agreed to a five-year suspension and a $15,000 civil penalty for ...

President Trump’s former surgeon general blasted Health and Human Services Secretary Robert F. Kennedy’s Jr.’s decision to fire the entirety of a federal advisory committee ...

UroGen Pharma received Food and Drug Administration approval for bladder cancer drug Zusduri, previously known as UGN-102. The company expects the drug will be available on or about July 1. It was ...

The psychedelics community is making a trip to Denver this month for what’s billed as the country’s largest conferences ...

The American Medical Association has adopted a new policy that calls for clinical AI tools that can explain their answers. It ...

As companies such as Elon Musk's Neuralink begin human trials of high-risk brain implants, a new proposal calls for a major ...

The randomized, phase 3 study is enrolling patients with metastatic kidney cancer who are initially treated with an ...

Rhythm Technologies, Inc.'s Q1 2025 growth, AI innovations, and market expansion. Click for why I upgraded IRTC to Buy ...